000 | 01997 a2200577 4500 | ||
---|---|---|---|
005 | 20250516230411.0 | ||
264 | 0 | _c20150526 | |
008 | 201505s 0 0 eng d | ||
022 | _a2211-1247 | ||
024 | 7 |
_a10.1016/j.celrep.2014.07.020 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLewis, Annabelle | |
245 | 0 | 0 |
_aA polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding. _h[electronic resource] |
260 |
_bCell reports _cAug 2014 |
||
300 |
_a983-90 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 | _aCDX2 Transcription Factor |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aColonic Neoplasms _xgenetics |
650 | 0 | 4 | _aEnhancer Elements, Genetic |
650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
650 | 0 | 4 | _aGenetic Association Studies |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 |
_aHomeodomain Proteins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntercellular Signaling Peptides and Proteins _xgenetics |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 | _aOrgan Specificity |
650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 |
_aTranscription Factor 7-Like 2 Protein _xmetabolism |
700 | 1 | _aFreeman-Mills, Luke | |
700 | 1 | _ade la Calle-Mustienes, Elisa | |
700 | 1 | _aGiráldez-Pérez, Rosa María | |
700 | 1 | _aDavis, Hayley | |
700 | 1 | _aJaeger, Emma | |
700 | 1 | _aBecker, Martin | |
700 | 1 | _aHubner, Nina C | |
700 | 1 | _aNguyen, Luan N | |
700 | 1 | _aZeron-Medina, Jorge | |
700 | 1 | _aBond, Gareth | |
700 | 1 | _aStunnenberg, Hendrik G | |
700 | 1 | _aCarvajal, Jaime J | |
700 | 1 | _aGomez-Skarmeta, Jose Luis | |
700 | 1 | _aLeedham, Simon | |
700 | 1 | _aTomlinson, Ian | |
773 | 0 |
_tCell reports _gvol. 8 _gno. 4 _gp. 983-90 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.celrep.2014.07.020 _zAvailable from publisher's website |
999 |
_c24105739 _d24105739 |